Cepheid has introduced the GeneXpert ® 16-Site System at the 106th Annual Meeting of the American Society for Microbiology. The latest addition to Cepheid's GeneXpert ® family of real-time PCR devices ...

Renowned molecular diagnostics provider Cepheid CPHD recently entered into a non-exclusive distribution agreement with Henry Schein Medical, the Medical business of one of the leading healthcare ...

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases OXFORD, United Kingdom and SUNNYVALE, Calif., ...

SpeeDx to bring first sample-to-answer Mycoplasma genitalium and macrolide resistance test to Europe SYDNEY--(BUSINESS WIRE)--SpeeDx Pty, Ltd. today announced the European launch of ResistancePlus® MG ...

SUNNYVALE, Calif., Sept. 19 Cepheid(Nasdaq: CPHD) today announced it has received two Veterans Affairs FederalSupply Service Schedule (VA/FSS) contracts for Cepheid's GeneXpert(R) Systemand the ...

SYDNEY--(BUSINESS WIRE)--SpeeDx Pty, Ltd. today announced ResistancePlus® MG FleXible for the Cepheid GeneXpert® System, detecting the sexually transmitted infection (STI) Mycoplasma genitalium (Mgen) ...

Cepheid, a leading molecular diagnostics company, and FIND, an international non-profit organisation, launched the GeneXpert Omni, the world's most portable molecular diagnostics system enabling ...

SUNNYVALE, Calif., Nov. 29 Cepheid(Nasdaq: CPHD) today announced it signed a group purchasing contract withBroadlane, a leading supply chain services company serving more than 20,000acute care ...

GeneXpert Anthrax tests combine sample preparation with real-time PCR (polymerase chain reaction) amplification and detection for fully automated DNA analysis. The system purifies, concentrates, ...

SUNNYVALE, Calif., Sept. 29, 2020 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress ...